Acne – Symptoms, Causes, Treatment and Dietary Support

Atopic dermatitis, commonly referred to as eczema (AZS), represents a multifaceted dermatological condition characterized by compromised epidermal barrier integrity, resulting in excessive transepidermal water loss and heightened susceptibility to allergen and pathogen penetration. Concurrently, the disease involves aberrant immune responses, frequently underpinned by IgE-mediated hypersensitivity. Genetic predispositions are pivotal in its pathogenesis, as evidenced by familial clustering studies. In numerous instances, AZS co-occurs with other atopic disorders—such as bronchial asthma or allergic rhinitis—forming what is termed the *atopic march*.

Atopic dermatitis, commonly referred to as eczema, represents a chronic inflammatory skin disorder with a complex immunologic basis, characterized by polymorphic cutaneous manifestations. In infants and young children, lesions predominantly emerge on the scalp, cheeks, and extensor surfaces of the limbs, whereas in adolescents and adults, the condition typically affects flexural regions—such as the antecubital and popliteal fossae—as well as the dorsum of the hands, wrists, forearms, and, less frequently, the face. The disease exhibits a dynamic course, with the morphology of skin lesions varying significantly depending on the current phase: acute flare-up, subacute period, or chronic state. Clinically, the condition presents with pruritic papules, serous vesicles, superficial erosions, and diffuse erythema. Prolonged disease duration often leads to lichenification—a thickening of the epidermis with accentuated skin markings—and the formation of deep furrows. A hallmark of the disorder is persistent, often paroxysmal pruritus, which tends to worsen in the evening and nocturnal hours. Exacerbating factors include abrupt environmental temperature fluctuations, contact with irritant fabrics (such as wool or synthetic fibers like acrylic), exposure to environmental allergens, and sweating. Psychogenic triggers also play a substantial role in disease relapse, with chronic emotional stress and anxiety disorders frequently precipitating or amplifying cutaneous symptoms.

Atopic dermatitis is characterized by profound disruptions in epidermal barrier integrity, facilitating heightened allergen penetration and moisture depletion. Keratinocytes—the predominant cells of the stratum corneum—respond to stimulation by releasing pro-inflammatory mediators, including cytokines such as IL-4 and IL-13, which orchestrate the recruitment of immune cells (e.g., Th2 lymphocytes, macrophages, and eosinophils), thereby amplifying local inflammatory responses. Furthermore, individuals with atopic dermatitis exhibit a deficiency in intercellular lipids, particularly ceramides, which compromises the cohesive structure of the stratum corneum, elevates transepidermal water loss (TEWL), and perpetuates chronic xerosis. Symptom exacerbation may be triggered by environmental factors, such as reduced ambient humidity, excessive cleansing with harsh detergents, exposure to irritants (e.g., wool, fragrances), and the ingestion of specific allergenic foods.

Atopic dermatitis (AD), commonly referred to as eczema, represents a chronic inflammatory skin condition for which no definitive cure currently exists. The overarching objectives of clinical management are therefore centered on mitigating symptomatic burden and preventing recurrent flare-ups. Pharmacological intervention primarily relies on glucocorticoids—administered topically and, in cases of severe exacerbation, systemically—to rapidly suppress acute inflammatory responses. Antihistamines are frequently incorporated into treatment regimens to alleviate pruritus, a distressing symptom that exacerbates skin lesions through scratching and impedes epidermal repair. Non-pharmacological strategies constitute an equally critical component of comprehensive AD management. Foremost among these is meticulous skin care, with an emphasis on sustained hydration. Contrary to common belief, water exposure (e.g., during bathing) does not hydrate atopic skin but rather exacerbates dryness; thus, individuals with AD must apply specialized emollients immediately after any contact with water. High-potency formulations containing urea or lactic acid are available for severely xerotic skin. Psychosocial factors also warrant attention, as emotional stress is a well-documented trigger for AD symptom intensification. Stress reduction techniques should therefore be integrated into holistic care plans. For refractory cases, controlled phototherapy utilizing ultraviolet (UV) radiation may serve as a viable adjunctive treatment. It is imperative to note, however, that commercial tanning beds do not provide a safe or medically endorsed alternative to clinically supervised phototherapeutic protocols.

Currently, there are no clear, evidence-based dietary guidelines established for patients with atopic dermatitis (AD). Nonetheless, it is critically important to exclude confirmed food allergens from the diet, as their consumption can significantly exacerbate the course of the disease and intensify skin lesions. In some individuals, IgE-mediated allergy may be suspected if characteristic symptoms—such as hives, nausea, vomiting, or even respiratory distress—develop shortly after ingesting a particular food (typically within two hours). Therefore, individuals with AD should diligently monitor their body’s responses to consumed meals, as there is also a phenomenon known as *food-responsive eczema*, wherein symptoms may manifest or worsen only 6 to 48 hours after allergen exposure. It is essential to emphasize, however, that arbitrarily eliminating foods without prior confirmation of a food allergy is not advisable, as this may lead to nutritional deficiencies. Diagnosis relies primarily on meticulous clinical observation, since both skin prick tests and IgE antibody level assessments frequently yield false-positive results, complicating the precise identification of the offending allergen.